These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pegylated human recombinant leptin (PEG-OB) causes additional weight loss in severely energy-restricted, overweight men. Hukshorn CJ; Westerterp-Plantenga MS; Saris WH Am J Clin Nutr; 2003 Apr; 77(4):771-6. PubMed ID: 12663271 [TBL] [Abstract][Full Text] [Related]
7. Short-term very low-calorie diet in obese females improves the haemostatic balance through the reduction of leptin levels, PAI-1 concentrations and a diminished release of platelet and leukocyte-derived microparticles. Morel O; Luca F; Grunebaum L; Jesel L; Meyer N; Desprez D; Robert S; Dignat-George F; Toti F; Simon C; Goichot B Int J Obes (Lond); 2011 Dec; 35(12):1479-86. PubMed ID: 21386797 [TBL] [Abstract][Full Text] [Related]
8. Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration in obese men. Hukshorn CJ; Saris WH; Westerterp-Plantenga MS; Farid AR; Smith FJ; Campfield LA J Clin Endocrinol Metab; 2000 Nov; 85(11):4003-9. PubMed ID: 11095423 [TBL] [Abstract][Full Text] [Related]
9. Effects of very low calorie diet induced body weight loss with or without human pegylated recombinant leptin treatment on changes in ghrelin and adiponectin concentrations. Lejeune MP; Hukshorn CJ; Saris WH; Westerterp-Plantenga MS Physiol Behav; 2007 Jun; 91(2-3):274-80. PubMed ID: 17434547 [TBL] [Abstract][Full Text] [Related]
10. A nutrigenomic inflammation-related PBMC-based approach to predict the weight-loss regain in obese subjects. Goyenechea E; Parra D; Crujeiras AB; Abete I; Martínez JA Ann Nutr Metab; 2009; 54(1):43-51. PubMed ID: 19246894 [TBL] [Abstract][Full Text] [Related]
11. The effect of pegylated recombinant human leptin (PEG-OB) on weight loss and inflammatory status in obese subjects. Hukshorn CJ; van Dielen FM; Buurman WA; Westerterp-Plantenga MS; Campfield LA; Saris WH Int J Obes Relat Metab Disord; 2002 Apr; 26(4):504-9. PubMed ID: 12075577 [TBL] [Abstract][Full Text] [Related]
12. Mild weight loss reduces inflammatory cytokines, leukocyte count, and oxidative stress in overweight and moderately obese participants treated for 3 years with dietary modification. Chae JS; Paik JK; Kang R; Kim M; Choi Y; Lee SH; Lee JH Nutr Res; 2013 Mar; 33(3):195-203. PubMed ID: 23507225 [TBL] [Abstract][Full Text] [Related]
13. The protein type within a hypocaloric diet affects obesity-related inflammation: the RESMENA project. Lopez-Legarrea P; de la Iglesia R; Abete I; Navas-Carretero S; Martinez JA; Zulet MA Nutrition; 2014 Apr; 30(4):424-9. PubMed ID: 24607301 [TBL] [Abstract][Full Text] [Related]
14. Effects of weight loss from a high-calcium energy-reduced diet on biomarkers of inflammatory stress, fibrinolysis, and endothelial function in obese subjects. Torres MR; Sanjuliani AF Nutrition; 2013 Jan; 29(1):143-51. PubMed ID: 23010419 [TBL] [Abstract][Full Text] [Related]
15. Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome. Mertens I; Verrijken A; Michiels JJ; Van der Planken M; Ruige JB; Van Gaal LF Int J Obes (Lond); 2006 Aug; 30(8):1308-14. PubMed ID: 16389265 [TBL] [Abstract][Full Text] [Related]
16. Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery. van Dielen FM; Buurman WA; Hadfoune M; Nijhuis J; Greve JW J Clin Endocrinol Metab; 2004 Aug; 89(8):4062-8. PubMed ID: 15292349 [TBL] [Abstract][Full Text] [Related]
17. Obesity and body fat classification in the metabolic syndrome: impact on cardiometabolic risk metabotype. Phillips CM; Tierney AC; Perez-Martinez P; Defoort C; Blaak EE; Gjelstad IM; Lopez-Miranda J; Kiec-Klimczak M; Malczewska-Malec M; Drevon CA; Hall W; Lovegrove JA; Karlstrom B; Risérus U; Roche HM Obesity (Silver Spring); 2013 Jan; 21(1):E154-61. PubMed ID: 23505198 [TBL] [Abstract][Full Text] [Related]
18. Effect of weight loss on high-molecular weight adiponectin in obese children. Martos-Moreno GÁ; Barrios V; Martínez G; Hawkins F; Argente J Obesity (Silver Spring); 2010 Dec; 18(12):2288-94. PubMed ID: 20339359 [TBL] [Abstract][Full Text] [Related]
19. Overweight Latino children and adolescents have marked endothelial dysfunction and subclinical vascular inflammation in association with excess body fat and insulin resistance. Caballero AE; Bousquet-Santos K; Robles-Osorio L; Montagnani V; Soodini G; Porramatikul S; Hamdy O; Nobrega AC; Horton ES Diabetes Care; 2008 Mar; 31(3):576-82. PubMed ID: 18083792 [TBL] [Abstract][Full Text] [Related]
20. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial. De Jager J; Kooy A; Lehert P; Bets D; Wulffelé MG; Teerlink T; Scheffer PG; Schalkwijk CG; Donker AJ; Stehouwer CD J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]